Company Profile
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical develops, manufactures, and sells biopharmaceutical products in the People's Republic of China. It offers photodynamic technology drugs, such as aminolevulinic acid hydrochloride and hemoporfin for Injection.
Its portfolio also includes doxorubicin liposome under the Libord brand, genetic engineering drugs, and oral solid preparation technology drugs. Founded in 1996, the company is based in Shanghai, the People's Republic of China.